What Researchers Did
Researchers reported on three cases where a specialized hyperbaric oxygen treatment, COMEX 30, was used to successfully treat severe neurological decompression sickness.
What They Found
The study found that in all three reported cases of severe neurological decompression sickness, treatment using the COMEX 30 recompression table successfully resolved the patients' neurological symptoms. This suggests that COMEX 30 can be an effective option when standard treatments like USN TT6 are insufficient for serious diving injuries.
What This Means for Canadian Patients
The findings suggest that advanced treatment tables like COMEX 30 could be crucial for Canadian divers experiencing severe neurological decompression sickness, especially when standard treatments are not enough. Access to specialized hyperbaric centres with trained staff and appropriate equipment is vital for optimal outcomes in such diving emergencies.
Canadian Relevance
This study covers decompression sickness, which is a Health Canada-recognized indication for hyperbaric oxygen therapy. While the study itself was not conducted in Canada, its findings are relevant for Canadian divers and the hyperbaric medical community.
Study Limitations
As a case report, this study's findings are based on a very small number of patients and may not apply to all individuals with severe neurological decompression sickness.